Immunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast

Indian Journal of Experimental Biology

Volumn 37, Issue 3, 1999, Pages 223-227

  Sharma, B K ^a   Ray, A ^a   Kaur, S ^a   Gupta, Sanjay ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; BREAST CARCINOMA; ENZYME SUBSTRATE; GENE MUTATION; GENETIC RISK; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE C ERB; ONCOGENE NEU; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033064420     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Parking D M, Piami P & Ferley J, Int J Cancer, 54 (1993) 594.
2. Annual Report, National Cancer Registry Programme, Indian Council of Medical Research, New Delhi 1988-89.
3. Farewell V T, Bulbrook R D & Hayward J L, in Early diagnosis of breast cancer, edited by E. Grandmann & L. Beck Gustav Fisher (Verlag Stuttgart, New York) 1978, 43.
4. Gajalakshmi C K & Shanta V, Acta Oncologica, 30 (1991) 569.
5. Tomatis L (Ed.), Cancer causes, occurrence and control (I.A.R.C. Scientific Publication, Lyon) 1990, 69.
6. Hill P, Am J Clin Nutr, 53 (1991) 798.
7. Hulka B S & Stark A T, Lancet, 346 (1995) 883.
8. Miller W R, Lancet, 341 (1993) 25.
9. Kelsey J L, Gammon M D & John E M, Epidemiol Rev, 15 (1993) 36.
10. Rosner B, Colditz G & Willet W, Am J Epidemiol, 139 (1994) 819.
11. Key T J A & Beral V, in, Mechanisms of carcinogenesis in risk identifiation, edited by Vainio H et al. (I.A.R.C. Scientific Publication, Lyon) 1992, 255.
12. Weber B L & Garber J E, J A M A, 270 (1993) 1602.
13. King M C, Rowell S Love S M, J A M A, 269 (1993) 1975.
14. Rochefort H, Eur J Cancer, 30A (1994) 1583.
15. Lelle R J, Heidenreich W, Stanch G & Gerdes J, Cancer, 59 (1987) 83.
16. Elston C W, in, Diagnostic histopathology of the breast, edited by Page D L & Anderson T J (Churchill Livingston, Edinburgh) 1987, 300.
17. McCann A, Dervan P A, Johnston P A, Gullick W J & Carney D A, Cancer, 65 (1990) 88.
18. Paterson M C, Dietrich K D, Danyluk A, Baterson A H G, Less A W, Jamil N, Hanson J, Jeukins H, Krause B E, Mc Blain W A, Slamon D J & Fourney R M, Cancer Res, 51 (1991) 556.
19. Slamon D J, Clerk G M, Wong S G, Levin W J, Ullrich A, & Mcquire W L, Science, 235 (1987) 177.
20. Tandon A K, Clark G M, Chamness G C, Ullrich A & Mc Guire W L, Clin Oncl, 7 (1989) 1120.
21. Thor A D, Schwart L H, Koerner E C, Egerton S M, Skates S J, Yin S, Mc Kenzic S J, Pauicali D L, Marks P J, Fingert H J & Wood W C, Cancer Res, 49 (1989) 7147.
22. Ventre D J, Kumar S, Tugi N L & Gullick W J, Lancet,ii (1987) 69.
23. Mansour E G, Ravdin P M & Dressler L, Cancer, 74 (1994) 381.
24. Hynes N E & Stern D F, Biochim Biophys Acta, 1198 (1994) 165.
25. Dalton L W, Page D L & Dupont W O, Cancer, 73 (1994) 2765.
26. Bloom H J C & Richardson W W, Br J Cancer, 11 (1957) 359.
27. Ratnakar N, Sharma B K, Chaturvedi U K, Kaur S, Naik D S L & Ray A, APMIS, 106 (1998) (in press).
28. Perez R, Pascual M, Macias A & Lage A, Breast Cancer Res Treat, 4 (1934) 189.
29. Macias A, Azavedo E, Hagerstrom T, Klintenberg C, Perez R & Skoog L, Anticancer Res, 7 (1987) 459.
30. Lipponen H J, Aaltomaa S, Syrjanen S & Synjanen K, Anticancer Res, 13 (1993) 1147.
31. Marks J R, Humphrey P A, Wu K, Berry D, Bandarenko N, Kerns B J & Iglehart D, Ann Surg, 219 (1994) 332.
32. Tsuda H, Iwaya K, Fukukoni T & Hirohashi S, Jpn J Cancer Res, 84 (1993) 394.
33. Wiltschke C, Kindas-Muegge J, Steininger A, Reiner A, Reiner G & Preis PN,J Cancer Res Clin Oncol, 120 (1994) 737.
34. Castiglioni T, Elsner B, Curutchet H P, Montesinos M & Debonis D, Medicine B Aires, 55 (1995) 415.
35. Barbati A, Cosmi E V, Sidoni A, Collini P, Porpora M G, Ferri I, Luthy M, Lauro V Bucciarell E, Anticancer Res, 17 (1997) 401.
36. Sato T, Yuyama Y, Watabe K, Okazaki A, Toda K, Okazaki M & Hirata K, Cancer Lett, 115 (1997) 47.
37. Elledge R M, Green S, Howes L, Clark G M, Berardo M, Allred D C, Pugh R, Ciocca D, Ravdin P, O'Sullivan J, Rivkin S, Martino S & Osborne C K, J Clin Oncol, 15 (1997) 1916.
38. Chu J S, Lee W J, Chang K J & Hsu H C, J Formos Med Assoc, 96 (1997) 237.
39. van der Kooy K, Rookus M A, Peterse H L & van Lecuwen F E, Am J Epidemiol, 14 (1996) 924.
40. Chen T H, Cai J J, Lu Y D, Chung Hua Chung L iu Tsa Chin, 16 (1994) 266.
41. Younes M, Lebovitz R M, Bommer K F, Cagle P T, Morton D, Khan S & Laucirica R, Hum Pathol 26 (1995) 155.
42. Rosen P P, Lesser M L, Arroyo C D, Cranor M, Borgen P & Norton L, J Clin Oncol, 13 (1995) 821.
43. Rudas M, Neumayer R, Gnant M F, Mittelbock M, Jaker Z R & Reiner A, Eur J Cancer, 33 (1997) 39.
44. Moriki T, Takahashi T, Hiroi M, Yamane T & Hara H, Pathol Int, 46 (1996) 417.
45. Charpin C, DeVictor B, Andrac L, Amabile J, Bergeret D, La Vant M N, Allasia C & Piana L, Hum Pathol, 26 (1995) 159.
46. Eriksson E T, Schimmelpenning H, Aspenblad U, Zetterberg A & Auer G U, Hum Pathol, 25 (1994) 1228.
47. Ramachandra S, Machin L, Ashleys Monaghan P &. Guesterson A, J Pathol, 161 (1990) 7.